210 related articles for article (PubMed ID: 36568979)
41. Integrated Characterization of MicroRNA and mRNA Transcriptome in Papillary Thyroid Carcinoma.
Mohamad Yusof A; Jamal R; Muhammad R; Abdullah Suhaimi SN; Mohamed Rose I; Saidin S; Ab Mutalib NS
Front Endocrinol (Lausanne); 2018; 9():158. PubMed ID: 29713312
[TBL] [Abstract][Full Text] [Related]
42. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.
Feng Y; Min Y; Chen H; Xiang K; Wang X; Yin G
J Endocrinol Invest; 2021 Oct; 44(10):2203-2211. PubMed ID: 33586026
[TBL] [Abstract][Full Text] [Related]
43. Magnetic Resonance Imaging Characteristics of Papillary Thyroid Carcinoma for the Prediction of Cervical Central Compartment Lymph Node Metastasis.
Wang H; Liu K; Ren J; Liu W; Chen Y; Song B
J Comput Assist Tomogr; 2019; 43(6):963-969. PubMed ID: 31162232
[TBL] [Abstract][Full Text] [Related]
44. MKL1 overexpression predicts poor prognosis in patients with papillary thyroid cancer and promotes nodal metastasis.
Cheng X; Xu S; Pan J; Zheng J; Wang X; Yu H; Bao J; Xu Y; Guan H; Zhang L
J Cell Sci; 2019 Aug; 132(16):. PubMed ID: 31363007
[TBL] [Abstract][Full Text] [Related]
45. [Clinicopathological factors in risk prediction of lymph node metastasis in papillary thyroid carcinoma].
Yue C; Zhang Y; Xing L; Zhao Y; Chen J; Jin Y; Liu H
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(46):3637-41. PubMed ID: 25622954
[TBL] [Abstract][Full Text] [Related]
46. Relationships between Lymph Node Metastasis and Expression of CD31, D2-40, and Vascular Endothelial Growth Factors A and C in Papillary Thyroid Cancer.
Lee SH; Lee SJ; Jin SM; Lee NH; Kim DH; Chae SW; Sohn JH; Kim WS
Clin Exp Otorhinolaryngol; 2012 Sep; 5(3):150-5. PubMed ID: 22977712
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma.
Chen W; Li G; Li Z; Zhu J; Wei T; Lei J
Endocrine; 2022 Mar; 75(3):846-855. PubMed ID: 34854020
[TBL] [Abstract][Full Text] [Related]
48. Ultrasonographic Features, Nodule Size, Capsular Invasion, and Lymph Node Metastasis of Solitary Papillary Carcinoma of Thyroid Isthmus.
Luo H; Yan F; Lan L; Ma B; Zhao H; He Y; Peng Y
Front Oncol; 2020; 10():558363. PubMed ID: 33117691
[No Abstract] [Full Text] [Related]
49. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
Wu M; Yuan H; Li X; Liao Q; Liu Z
Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
[No Abstract] [Full Text] [Related]
50. Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size.
Zhang X; Chen W; Fang Q; Fan J; Feng L; Guo L; Liu S; Ge H; Du W
Front Endocrinol (Lausanne); 2021; 12():716082. PubMed ID: 34335480
[TBL] [Abstract][Full Text] [Related]
51. Enhanced stiffness in peri-cancerous tissue: a marker of poor prognosis in papillary thyroid carcinoma with lymph node metastasis.
Hu L; Ye L; Pei C; Sun C; Zhang C; Jiang F; He N; Lv W
Oncologist; 2024 Jun; ():. PubMed ID: 38902966
[TBL] [Abstract][Full Text] [Related]
52. Prognostic Significance of KIF-12 Functioning as a Tumour Suppressor in Papillary Thyroid Carcinoma.
Gao L; Liu R; Xia Y; Pan A; Shi X; Ma L; Ji J; Hu Y; Li X; An Y; Luo N; Liang Z; Zhou L; Jiang Y
J Cancer; 2024; 15(8):2206-2213. PubMed ID: 38495495
[No Abstract] [Full Text] [Related]
53. Clinical implications of Delphian lymph node metastasis in papillary thyroid carcinoma.
Zhu J; Huang R; Yu P; Hu D; Ren H; Huang C; Su X
Gland Surg; 2021 Jan; 10(1):73-82. PubMed ID: 33633964
[TBL] [Abstract][Full Text] [Related]
54. Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma.
Shi J; Wu P; Sheng L; Sun W; Zhang H
Cancer Cell Int; 2021 Dec; 21(1):669. PubMed ID: 34906147
[TBL] [Abstract][Full Text] [Related]
55. A novel tumor suppressor gene
Zheng ZC; Wang QX; Zhang W; Zhang XH; Huang DP
Onco Targets Ther; 2018; 11():307-311. PubMed ID: 29391807
[TBL] [Abstract][Full Text] [Related]
56. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
[TBL] [Abstract][Full Text] [Related]
57. Expression of EMT-related genes in lymph node metastasis in endometrial cancer: a TCGA-based study.
Li H; Wang J; Li L; Zhao L; Wang Z
World J Surg Oncol; 2023 Feb; 21(1):55. PubMed ID: 36814242
[TBL] [Abstract][Full Text] [Related]
58. Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma.
Qin R; Li C; Wang X; Zhong Z; Sun C
Cancer Cell Int; 2021 Jul; 21(1):378. PubMed ID: 34266418
[TBL] [Abstract][Full Text] [Related]
59. Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with
Li GY; Tan HL; Chen P; Hu HY; Liu M; Ou-Yang DJ; Khushbu RA; Pun D; Li JD; Zhang ZP; Yang Q; Huang P; Chang S
Cancer Manag Res; 2020; 12():3371-3378. PubMed ID: 32494201
[TBL] [Abstract][Full Text] [Related]
60. Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis.
Tang W; Huang C; Tang C; Xu J; Wang H
Onco Targets Ther; 2016; 9():455-60. PubMed ID: 26858526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
